@a4zhqvu118
active 4 years, 3 months ago
Alfuzosin is a α1 receptor antagonist that works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. It is marketed in the United States by Sanofi Aventis under the brand name Uroxatral and elsewhere under the tradename Xatral. FDA approved Alfuzosin in June 2003 for the treatment of BPH.™The two main […] View
-
a4zhqvu118 posted an update 4 years, 3 months ago
Alfuzosin is a α1 receptor antagonist that works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. It is marketed in the United States by Sanofi Aventis under the brand name Uroxatral and elsewhere under the tradename Xatral. FDA approved Alfuzosin in June 2003 for the treatment of BPH.™The two main medications…[Read more]
-
a4zhqvu118 became a registered member 4 years, 3 months ago
